Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SLN compared with ANNX: revenue, margins and what each company keeps, and the suppliers and customers both name
SLN
Silence Therapeutics plc
Change
Mkt cap
Revenue
Revenue
ANNX
Annexon, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SLN
Silence Therapeutics plc
vs
ANNX
Annexon, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SLN: latest quarter is a loss; flow not drawable. ANNX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SLN
2
AZN
AstraZeneca AB
customer
—
Hansoh Pharmaceutical
unlisted
customer
Shared
0
No disclosed counterparties: ANNX.
Only ANNX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SLN, solid
ANNX, dashed
SLN
Silence Therapeutics plc
Change
19.76
· pre 19.76
· delayed
Mkt cap
$933.1M
Revenue
$422,000
Q1 FY26
Revenue
$559,000
FY25
ANNX
Annexon, Inc.
Change
4.07
· pre 4.09
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$828.0M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
SLN
Silence Therapeutics plc
vs
ANNX
Annexon, Inc.
19.76
pre 19.76
delayed
Price
4.07
pre 4.09
delayed
$933.1M
Mkt cap
$828.0M
Q1 FY26
$422,000
Revenue
—
FY25
$559,000
Revenue
—
Change
Change
SLN
19.76
vs
ANNX
4.07
Pre-market
Oct 30 '26
delayed